Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04555187 · ClinicalTrials.gov registry record
Cardiovascular Risk Stratification in Covid-19
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 1,355
- Enrollment target
NCT04555187 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 1,355 participants.
The verdict
NCT04555187 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 1,355 participants
- Enrollment target
Study Summary
This retrospective double-cohort study seeks to: 1. Describe the cardiovascular manifestations and electrophysiological (EP) substrate in COVID-19 infection and their association with clinical outcomes; and 2. Develop a method of cardiovascular risk stratification in COVID-19
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,355 participants |
| Start Date | 2020-06-08 |
| Est. Completion | 2021-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04555187
The ClinicalTrials.gov registry entry for NCT04555187 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,355 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04555187 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04555187 about?
NCT04555187 is a clinical study titled "Cardiovascular Risk Stratification in Covid-19". This retrospective double-cohort study seeks to: 1. Describe the cardiovascular manifestations and electrophysiological (EP) substrate in COVID-19 infection and their association with clinical outcomes; and 2. Develop a method of cardiovascular risk stratification in COVID-19
What is the current status of trial NCT04555187?
This trial is currently completed. The enrollment target is 1,355 participants. The study started on 2020-06-08. Estimated completion is 2021-12-01.
Who is sponsoring clinical trial NCT04555187?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.